IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (AMEX: COR, http://www.cortexpharm.com) reported a net loss of $4,371,000, or $0.09 per share for the quarter ended March 31, 2008 compared with a net loss of $3,884,000, or $0.10 per share for the corresponding prior year period. Non-cash stock-based compensation charges for the quarters ended March 31, 2008 and 2007 totaled approximately $408,000 and $653,000, respectively. On the balance sheet, cash and marketable securities as of March 31, 2008 totaled approximately $14,000,000.
